{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:59:32Z","timestamp":1786982372709,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Alma Mater Studiorum - Universit\u00e0 di Bologna"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Musculoskelet Surg"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Pigmented Villonodular Synovitis (PVNS) is a proliferative disease arising from the synovial membrane, mainly affects large joints such as the knee (almost 80% of total). Prostheses implanted in PVNS osteoarthritis show a higher revision rate when compared to primary osteoarthritis, due to the recurrence of disease and the overall surgical complications. The purpose of this systematic review is to summarize and compare indications, clinical and functional outcomes, disease-related and surgical-related complications of total knee arthroplasty in PVNS osteoarthritis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>A systematic review of the literature was performed with a primary search on Medline through PubMed. The PRISMA 2009 flowchart and checklist were used to edit the review. Screened studies had to provide preoperative diagnosis, previous treatments, main treatment, concomitant strategies, mean follow-up, outcomes and complications to be included in the review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 8 articles were finally included. Most of papers reported the use of non-constrained design implants, mainly posterior stabilized (PS) and in case of PVNS with extensive joint involvement implants with higher degree of constraint to obtain a fulfilling balancing. Recurrence of PVNS has been indicated as the major complication, followed by aseptic loosening of the implant and difficult post-operative course with an increased risk of stiffness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Total knee arthroplasty represents a valid treatment for patients with PVNS end-stage osteoarthritis, with good clinical and functional results, even in longer follow-up. It would be advisable a multidisciplinary management and a meticulous rehabilitation and monitoring following the procedure, to reduce the emergence of recurrence and overall complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12306-023-00793-y","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T06:01:52Z","timestamp":1687240912000},"page":"145-152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Total knee arthroplasty in pigmented villonodular synovitis osteoarthritis: a systematic review of literature"],"prefix":"10.1007","volume":"108","author":[{"given":"A.","family":"Panciera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Colangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Di Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. D.","family":"Bulzacki Bogucki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cecchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9376-5480","authenticated-orcid":false,"given":"M.","family":"Brunello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Benvenuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Digennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"key":"793_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s43019-021-00088-1","author":"YC Tan","year":"2021","unstructured":"Tan YC, Tan JY, Tsitskaris K (2021) Systematic review: total knee arthroplasty (TKA) in patients with pigmented villonodular synovitis (PVNS). Knee Surg Relat Res. https:\/\/doi.org\/10.1186\/s43019-021-00088-1","journal-title":"Knee Surg Relat Res"},{"key":"793_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/17453674.2016.1205168","volume":"87","author":"FGM Verspoor","year":"2016","unstructured":"Verspoor FGM, Hannink G, Scholte A, Van Der Geest ICM, Schreuder HWB (2016) Arthroplasty for tenosynovial giant cell tumors: 17 patients followed for 0.2 to 15 years. Acta Orthop 87:497\u2013503","journal-title":"Acta Orthop"},{"key":"793_CR3","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.rbo.2016.08.007","volume":"52","author":"LFB Pinheiro","year":"2017","unstructured":"Pinheiro LFB, Cenni MHF, Leal RHS, Teixeira LEM (2017) Total knee replacement in patients with diffuse villonodular synovitis. Revista Brasileira de Ortopedia. 52:616\u2013620","journal-title":"Revista Brasileira de Ortopedia."},{"key":"793_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1055\/s-0039-1694736","volume":"34","author":"W Su","year":"2021","unstructured":"Su W et al (2021) Short-term outcomes of synovectomy and total knee replacement in patients with diffuse-type pigmented villonodular synovitis. J Knee Surg 34:247\u2013250","journal-title":"J Knee Surg"},{"key":"793_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.artd.2018.06.006","volume":"4","author":"C Kia","year":"2018","unstructured":"Kia C et al (2018) An unusual case of pigmented villonodular synovitis after total knee arthroplasty presenting with recurrent hemarthrosis. Arthroplast Today 4:426\u2013430","journal-title":"Arthroplast Today"},{"key":"793_CR6","doi-asserted-by":"publisher","DOI":"10.2217\/fon.13.124","author":"FGM Verspoor","year":"2013","unstructured":"Verspoor FGM et al (2013) Pigmented villonodular synovitis: current concepts about diagnosis and management. Future Oncol. https:\/\/doi.org\/10.2217\/fon.13.124","journal-title":"Future Oncol"},{"issue":"4","key":"793_CR7","first-page":"550","volume":"97-B","author":"B Mollon","year":"2015","unstructured":"Mollon B et al (2015) The effect of surgical synovectomy and radiotherapy on the rate of recurrence of pigmented villonodular synovitis of the knee: an individual patient meta-analysis. Bone and Joint Journal 97-B(4):550\u2013557","journal-title":"Bone and Joint Journal"},{"issue":"7","key":"793_CR8","first-page":"984","volume":"100B","author":"Y Gortzak","year":"2018","unstructured":"Gortzak Y et al (2018) Inconclusive benefit of adjuvant 90Yttrium hydroxyapatite to radiosynovectomy for diffuse-type tenosynovial giant-cell tumour of the knee. Bone and Joint Journal 100B(7):984\u2013988","journal-title":"Bone and Joint Journal"},{"issue":"5","key":"793_CR9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00402-018-3097-4","volume":"139","author":"HR D\u00fcrr","year":"2019","unstructured":"D\u00fcrr HR et al (2019) The effects of radiosynoviorthesis in pigmented villonodular synovitis of the knee. Arch Orthop Trauma Surg 139(5):623\u2013627","journal-title":"Arch Orthop Trauma Surg"},{"key":"793_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-28026-2_29","author":"G M\u00f6dder","year":"2007","unstructured":"M\u00f6dder G (2007) Radiosynoviorthesis (radiation synovectomy). Clin Nucl Med. https:\/\/doi.org\/10.1007\/978-3-540-28026-2_29","journal-title":"Clin Nucl Med"},{"key":"793_CR11","first-page":"99","volume":"59","author":"DG Mohler","year":"2000","unstructured":"Mohler DG, Kessler BD (2000) Open synovectomy with cryosurgical adjuvant for treatment of diffuse pigmented villonodular synovitis of the knee. Bull Hosp Joint Dis 59:99\u2013105","journal-title":"Bull Hosp Joint Dis"},{"issue":"3","key":"793_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1136\/ard.2004.025692","volume":"64","author":"EJA Kroot","year":"2005","unstructured":"Kroot EJA et al (2005) Tumour necrosis factor \u03b1 blockade in treatment resistant pigmented villonodular synovitis. Ann Rheum Dis 64(3):497\u2013499","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"793_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00296-009-1185-z","volume":"31","author":"S Kobak","year":"2011","unstructured":"Kobak S (2011) Intraarticular adalimumab in a patient with pigmented villonodular synovitis. Rheumatol Int 31(2):251\u2013254","journal-title":"Rheumatol Int"},{"issue":"4","key":"793_CR14","first-page":"268","volume":"58","author":"U Fiocco","year":"2006","unstructured":"Fiocco U et al (2006) Intra-articular treatment with the TNF-alpha antagonist, etanercept, in severe diffuse pigmented villonodular synovitis of the knee. Reumatismo 58(4):268\u2013274","journal-title":"Reumatismo"},{"issue":"5","key":"793_CR15","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S1470-2045(18)30143-8","volume":"19","author":"H Gelderblom","year":"2018","unstructured":"Gelderblom H et al (2018) Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial. Lancet Oncol 19(5):639\u2013648","journal-title":"Lancet Oncol"},{"key":"793_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-51211-y","author":"FGM Verspoor","year":"2019","unstructured":"Verspoor FGM et al (2019) Long-term efficacy of imatinib mesylate in patients with advanced tenosynovial giant cell tumor. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-019-51211-y","journal-title":"Sci Rep"},{"issue":"10197","key":"793_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0140-6736(19)30764-0","volume":"394","author":"WD Tap","year":"2019","unstructured":"Tap WD et al (2019) Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial. The Lancet 394(10197):478\u2013487","journal-title":"The Lancet"},{"issue":"5","key":"793_CR18","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1411366","volume":"373","author":"WD Tap","year":"2015","unstructured":"Tap WD et al (2015) Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor. N Engl J Med 373(5):428\u2013437","journal-title":"N Engl J Med"},{"issue":"8","key":"793_CR19","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S1470-2045(15)00132-1","volume":"16","author":"PA Cassier","year":"2015","unstructured":"Cassier PA et al (2015) CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study. Lancet Oncol 16(8):949\u2013956","journal-title":"Lancet Oncol"},{"issue":"1","key":"793_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2106\/00004623-199801000-00013","volume":"80","author":"BR Hamlin","year":"1998","unstructured":"Hamlin BR, Duffy GP, Trousdale RT, Morrey BF (1998) Total knee arthroplasty in patients who have pigmented villonodular synovitis. J Bone Joint Surg 80(1):76\u201382","journal-title":"J Bone Joint Surg"},{"key":"793_CR21","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.arth.2016.12.053","volume":"32","author":"P Lei","year":"2017","unstructured":"Lei P et al (2017) Prognosis of advanced tenosynovial giant cell tumor of the knee diagnosed during total knee arthroplasty. J Arthroplasty 32:1850\u20131855","journal-title":"J Arthroplasty"},{"key":"793_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.04.022","author":"EL Staals","year":"2016","unstructured":"Staals EL, Ferrari S, Donati DM, Palmerini E (2016) Diffuse-type tenosynovial giant cell tumour: current treatment concepts and future perspectives. Eur J Cancer. https:\/\/doi.org\/10.1016\/j.ejca.2016.04.022","journal-title":"Eur J Cancer"},{"key":"793_CR23","unstructured":"Howick J et al. Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence. http:\/\/www.cebm.net\/index.aspx?o=5653."},{"key":"793_CR24","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.knee.2017.04.019","volume":"24","author":"MT Houdek","year":"2017","unstructured":"Houdek MT et al (2017) Long-term outcome of knee arthroplasty in the setting of pigmented villonodular synovitis. Knee 24:851\u2013855","journal-title":"Knee"},{"key":"793_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-020-01933-x","author":"W Lin","year":"2020","unstructured":"Lin W et al (2020) Pigmented villonodular synovitis does notinfluence the outcomes following cruciate-retaining total knee arthroplasty: a case-control study with minimum 5-year follow-up. J Orthop Surg Res. https:\/\/doi.org\/10.1186\/s13018-020-01933-x","journal-title":"J Orthop Surg Res"},{"issue":"3","key":"793_CR26","first-page":"64","volume":"16","author":"AA Alamari","year":"2022","unstructured":"Alamari AA, AlSuwayeh FM (2022) Total synovectomy and total knee arthroplasty in old patient with pigmented villonodular synovitis-a case report. Int J Health Sci 16(3):64","journal-title":"Int J Health Sci"},{"key":"793_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s12306-023-00790-1","author":"V Digennaro","year":"2023","unstructured":"Digennaro V et al (2023) Constraint degree in revision total knee replacement: a registry study on 1432 patients. Musculoskelet Surg. https:\/\/doi.org\/10.1007\/s12306-023-00790-1","journal-title":"Musculoskelet Surg"},{"issue":"3","key":"793_CR28","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s11999-012-2589-8","volume":"471","author":"MW Colman","year":"2013","unstructured":"Colman MW, Ye J, Weiss KR, Goodman MA, McGough RL (2013) Does combined open and arthroscopic synovectomy for diffuse PVNS of the knee improve recurrence rates? Tumor. Clin Orthopa Relate Res 471(3):883\u2013890","journal-title":"Clin Orthopa Relate Res"},{"key":"793_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.arth.2018.08.041","volume":"34","author":"AJ Casp","year":"2019","unstructured":"Casp AJ, Browne JA, Durig NE, Werner BC (2019) Complications after total knee arthroplasty in patients with pigmented villonodular synovitis. J Arthroplasty 34:36\u201339","journal-title":"J Arthroplasty"}],"container-title":["MUSCULOSKELETAL SURGERY"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12306-023-00793-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12306-023-00793-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12306-023-00793-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T09:28:51Z","timestamp":1716888531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12306-023-00793-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["793"],"URL":"https:\/\/doi.org\/10.1007\/s12306-023-00793-y","relation":{},"ISSN":["2035-5106","2035-5114"],"issn-type":[{"value":"2035-5106","type":"print"},{"value":"2035-5114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,20]]},"assertion":[{"value":"11 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}